A gene-environment interaction model of stress-induced hypertension

Cardiovascular Toxicology

Volumn 5, Issue 2, 2005, Pages 109-132

  Imumorin, Ikhide G ^a   Dong, Yanbin ^b   Zhu, Haidong ^b   Poole, Joseph C ^b   Harshfield, Gregory A ^b   Treiber, Frank A ^b   Snieder, Harold ^b,c  

^a SPELMAN COLLEGE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Essential hypertension; Gene environment interaction; Genetics; Stress

Indexed keywords

ADRENERGIC RECEPTOR; CATECHOLAMINE; DOPAMINE RECEPTOR;

ADRENERGIC SYSTEM; CATECHOLAMINE METABOLISM; CHOLINERGIC SYSTEM; ECOLOGICAL GENETICS; GENE INTERACTION; GENETIC SUSCEPTIBILITY; HEART; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KIDNEY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SODIUM ABSORPTION; VASCULARIZATION;

ANIMALS; CATECHOLAMINES; ENDOTHELIUM, VASCULAR; ENVIRONMENT; HUMANS; HYPERTENSION; MODELS, GENETIC; RENIN-ANGIOTENSIN SYSTEM; SODIUM; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 23044500298     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:5:2:109     Document Type: Review

References (210)

1. Stamler, J. (1991). Metabolic and nutritional factors in hypertension. Blood pressure and high blood pressure: aspects of risk. Hypertension 18:95-107.
2. Cheng, L.S., Livshits, G., Carmelli, D., Wahrendorf, J., and Brunner, D. (1998). Segregation analysis reveals a major gene effect controlling systolic blood pressure and BMI in an Israeli population. Hum. Biol. 70:59-75.
3. Mitchell, B.D., Kammerer, C.M., Blangero, J., Mahaney, M.C., Rainwater, D.L., Dyke, B., et al. (1996). Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 94:2159-2170.
4. Hong, Y., de Faire, U., Heller, D.A., McClearn, G.E., and Pedersen, N. (1994). Genetic and environmental influences on blood pressure in elderly twins. Hypertension 24:663-670.
5. Snieder, H. (2004). Familial aggregation of blood pressure. In Clinical Hypertension and Vascular Disease: Pediatric Hypertension (Portman, R.J., Sorof, J.M., and Ingelfinger, J.R., eds), Humana Press, Totowa, NJ, pp. 265-278.
6. Lifton, R.P. (1996). Molecular genetics of human blood pressure variation. Science 272:676-680.
7. Hamet, P., Pausova, Z., Adarichev, V., Adaricheva, K., and Tremblay, J. (1998). Hypertension: genes and environment. J. Hypertens. 16:397-418.
8. Snieder, H., Harshfield, G.A., Barbeau, P., Pollock, D.M., Pollock, J.S., and Treiber, P.A. (2002). Dissecting the genetic architecture of the cardiovascular and renal stress response. Biol. Psychol. 61:73-95.
9. Treiber, F.A. and Snieder, H. (2004). Cardiovascular reactivity in youth. In Clinical Hypertension and Vascular Disease: Pediatric Hypertension (Portman, R.J., Sorof, J.M., and Ingelfinger, J.R., eds), Humana Press, Totowa, NJ, pp. 251-263.
10. Manuck, S.B. (1994). Cardiovascular reactivity in cardiovascular disease: "Once more unto the breach". Int. J. Behav. Med. 1:4-31.
11. Kamarck, T.W. and Lovallo, W.R. (2003). Cardiovascular reactivity to psychological challenge: conceptual and measurement considerations. Psychosom. Med. 65:9-21.
12. Harshfield, G.A. and Grim, C.E. (1997). Stress hypertension: the "wrong" genes in the "wrong" environment. Acta Physiol. Scand. Suppl. 640:129-132.
13. Light, K.C., Girdler, S.S., Sherwood, A., Bragdon, E.E., Brownley, K.A., West, S.G., et al. (1999). High stress responsivity predicts later blood pressure only in combination with positive family history and high life stress. Hypertension 33:1458-1464.
14. Light, K.C. (2001). Hypertension and the reactivity hypothesis: the next generation. Psychosom. Med. 63:744-746.
15. Harshfield, G.A., Treiber, F.A., Davis, H., and Kapuku, G.K. (2002). Impaired stress-induced pressure natriuresis is related to left ventricular structure in Blacks. Hypertension 39:844-847.
16. Treiber, F.A., Kamarck, T., Schneiderman, N., Sheffield, D., Kapuku, G., and Taylor, T. (2003). Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom. Med. 65:46-62.
17. Ferrier, C., Cox, H., and Esler, M. (1993). Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci. (Lond.) 84:225-230.
18. Anderson, N.B. and Armstead, C.A. (1995). Toward understanding the association of socioeconomic status and health: a new challenge for the biopsychosocial approach. Psychosom. Med. 57:213-225.
19. Anderson, N.B., McNeilly, M., and Myers, H. (1992). Toward understanding race difference in autonomic reactivity. A proposed contextual model. In Individual differences in cardiovascular response to stress. (Turner, J.R., Sherwood, A., and Light, K.C., eds), Plenum Press, New York, pp. 125-145.
20. Thomas, K.S., Nelesen, R.A., Ziegler, M.G., Bardwell, W.A., and Dimsdale, J.E. (2004). Job strain, ethnicity, and sympathetic nervous system activity. Hypertension 44:891-896.
21. Miller, J.Z., Luft, F.C., Grim, C.E., Henry, D.P., Christian, J.C., and Weinberger, M.H. (1980). Genetic influences on plasma and urinary norepinephrine after volume expansion and contraction in normal men. J. Clin. Endocrinol. Metab. 50:219-222.
22. Williams, P.D., Puddey, I.B., Beilin, L.J., and Vandongen, R. (1993). Genetic influences on plasma catecholamines in human twins. J. Clin. Endocrinol. Metab. 77:794-799.
23. Wallin, B.G., Kunimoto, M.M., and Sellgren, J. (1993). Possible genetic influence on the strength of human muscle nerve sympathetic activity at rest. Hypertension 22:282-284.
24. Kuchel, O.G. and Kuchel, G.A. (1991). Peripheral dopamine in pathophysiology of hypertension. Interaction with aging and lifestyle. Hypertension 18:709-721.
25. Kuchel, O. (2003). Mental stress and hypertension, an evolutionary framework: some historical perspectives of the 1960 World Health Organization Prague Hypertension Meeting. J. Hypertens. 21:639-641.
26. Mannelli, M., Ianni, L., Lazzeri, C., Castellani, W., Pupilli, C., La Villa, G., et al. (1999). In vivo evidence that endogenous dopamine modulates sympathetic activity in man. Hypertension 34:398-402.
27. Schanberg, S.M., Stone, R.A., Kirshner, N., Gunnells, J.C., and Robinson, R.R. (1974). Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension. Science 183:523-525.
28. Barbeau, P., Litaker, M.S., Jackson, R.W., and Treiber, F.A. (2003). A tyrosine hydroxylase microsatellite and hemodynamic response to stress in a multi-ethnic sample of youth. Ethn. Dis. 13:186-192.
29. Jindra, A., Jachymova, M., Horky, K., Peleska, J., Umnerova, V., Bultas, J., and Savlikova, J. (2000). Association analysis of two tyrosine hydroxylase gene polymorphisms in normotensive offspring from hypertensive families. Blood Press. 9:250-254.
30. Linhart, A., Jindra, A., Golan, L., Jachymova, M., Sedlacek, K., Peleska, J., et al. (2002). Association between tyrosine hydroxylase polymorphisms and left ventricular structure in young normotensive men. Br. J. Biomed. Sci. 59:90-94.
31. Timmers, H.J., Deinum, J., Wevers, R.A., and Lenders, J.W. (2004). Congenital dopamine-beta-hydroxylase deficiency in humans. Ann. NY Acad. Sci. 1018:520-523.
32. Cubells, J.F., van Kammen, D.P., Kelley, M.E., Anderson, G.M., O'Connor, D.T., Price, L.H., et al. (1998). Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum. Genet. 102:533-540.
33. Zabetian, C.P., Anderson, G.M., Buxbaum, S.G., Elston, R.C., Ichinose, H., Nagatsu, T., et al. (2001). A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am. J. Hum. Genet. 68:515-522.
34. Zabetian, C.P., Buxbaum, S.G., Elston, R.C., Kohnke, M.D., Anderson, G.M., Gelernter, J., et al. (2003). The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am. J. Hum. Genet. 72:1389-1400.
35. Cui, J., Zhou, X., Chazaro, I., DeStefano, A.L., Manolis, A.J., Baldwin, C.T., et al. (2003). Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites. Am. J. Hypertens. 16:859-863.
36. Rumantir, M.S., Kaye, D.M., Jennings, G.L., Vaz, M., Hastings, J.A., and Esler, M.D. (2000). Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 36:824-829.
37. Ono, K., Iwanaga, Y., Mannami, T., Kokubo, Y., Tomoike, H., Komamura, K., et al. (2003). Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension. Hypertens. Res. 26:685-689.
38. Furlong, R.A., Ho, L., Rubinsztein, J.S., Walsh, C., Paykel, E.S., and Rubinsztein, D.C. (1999). Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter. Am. J. Med. Genet. 88:398-406.
39. Deckert, J., Catalano, M., Syagailo, Y.V., Bosi, M., Okladnova, O., Di Bella, D., et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 8:621-624.
40. Guimaraes, S. and Moura, D. (2001). Vascular adrenoceptors: an update. Pharmacol. Rev. 53:319-356.
41. Balligand, J.L. (1999). Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc. Res. 43:607-620.
42. Rosendorff, C. (1986). Alpha-adrenoreceptors in hypertension. J. Cardiovasc. Pharmacol. 8(Suppl. 2):S3-S7.
43. Li, G.H., Faulhaber, H.D., Rosenthal, M., Schuster, H., Jordan, J., Timmermann, B., et al. (2001). Beta-2 adrenergic receptor gene variations and blood pressure under stress in normal twins. Psychophysiol. 38:485-489.
44. McCaffery, J.M., Pogue-Geile, M.F., Ferrell, R.E., Petro, N., and Manuck, S.B. (2002). Variability within alpha-and beta-adrenoreceptor genes as a predictor of cardiovascular function at rest and in response to mental challenge. J. Hypertens. 20:1105-1114.
45. Snieder, H. and Treiber, F.A. (2002). The Georgia Cardiovascular Twin Study. Twin Res. 5:497-498.
46. Snieder, H., Dong, Y., Barbeau, P., Harshfield, G.A., Dalageogou, C., Zhu, H., et al. (2002). beta2-adrenergic receptor gene and resting hemodynamics in European and African American youth. Am. J. Hypertens. 15:973-979.
47. Finley, J.C. Jr., O'Leary, M., Wester, D., MacKenzie, S., Shepard, N., Farrow, S., et al. (2004). A genetic polymorphism of the alpha2-adrenergic receptor increases autonomic responses to stress. J. Appl. Physiol. 96:2231-2239.
48. Xie, H.G., Kim, R.B., Stein, C.M., Gainer, J.V., Brown, N.J., and Wood, A.J. (1999). Alphal A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension. Pharmacogenetics 9:651-656.
49. Small, K.M., Brown, K.M., Forbes, S.L., and Liggett, S.B. (2001). Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J. Biol. Chem. 276:4917-4922.
50. Hoffstedt, J., Poirier, O., Thorne, A., Lonnqvist, F., Herrmann, S.M., Cambien, F., et al. (1999). Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 48:203-205.
51. Small, K.M., Forbes, S.L., Rahman, F.F., Bridges, K.M., and Liggett, S.B. (2000). A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J. Biol. Chem. 275:23,059-23,064.
52. Bek, M.J., Eisner, G.M., Felder, R.A., and Jose, P.A. (2001). Dopamine receptors in hypertension. Mt. Sinai J. Med. 68:362-369.
53. Rosmond, R., Rankinen, T., Chagnon, M., Perusse, L., Chagnon, Y.C., Bouchard, C., et al. (2001). Polymorphism in exon 6 of the dopamine D(2) receptor gene (DRD2) is associated with elevated blood pressure and personality disorders in men. J. Hum. Hypertens. 15:553-558.
54. Thomas, G.N., Tomlinson, B., and Critchley, J.A. (2000). Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension 36:177-182.
55. Amenta, F., Ricci, A., Rossodivita, I., Avola, R., and Tayebati, S.K. (2001). The dopaminergic system in hypertension. Clin. Exp. Hypertens. 23:15-24.
56. Asico, L.D., Ladines, C., Fuchs, S., Accili, D., Carey, R.M., Semeraro, C., et al. (1998). Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J. Clin. Invest. 102:493-498.
57. Yang, Z., Asico, L.D., Yu, P., Wang, Z., Jones, J.E., Bai, R.K., et al. (2005). D5 dopamine receptor regulation of phospholipase D. Am. J. Physiol. Heart Circ. Physiol. 288:H55-H61.
58. Steinberg, S.F. (1999). The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ. Res. 85:1101-1111.
59. Siffert, W., Rosskopf, D., Siffert, G., Busch, S., Moritz, A., Erbel, R., et al. (1998). Association of a human G-protein beta3 subunit variant with hypertension. Nat. Genet. 18:45-48.
60. Yoshikawa, H., Fukuda, K., Wanaka, Y., Kasamatsu, K., Baba, A., Nishio, I., et al. (1994). Deficient activity of stimulatory nucleotide-binding regulatory protein in lymphocytes from patients with essential hypertension. Am. J. Hypertens. 7:713-716.
61. Feldman, R.D., Tan, C.M., and Chorazyczewski, J. (1995). G protein alterations in hypertension and aging. Hypertension 26:725-732.
62. Dong, Y., Zhu, H., Wang, X., Dalageorgou, C., Carter, N., Spector, T.D., et al. (2004). Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins. Pharmacogenetics 14:419-427.
63. Dong, Y., Zhu, H., Sagnella, G.A., Carter, N.D., Cook, D.G., and Cappuccio, F.P. (1999). Association between the C825T polymorphism of the G protein β3-subunit gene and hypertension in blacks. Hypertension 34:1193-1196.
64. Dong, Y. (2000). The G protein beta3 subunit polymorphism in human hypertension. Int. J. Cardiol. 73:197-198.
65. Jia, H., Hingorani, A.D., Sharma, P., Hopper, R., Dickerson, C., Trutwein, D., et al. (1999). Association of the G(s) alpha gene with essential hypertension and response to beta-blockade. Hypertension 34:8-14.
66. Yasuda, K., Matsunaga, T., Moritani, T., Nishikino, M., Gu, N., Yoshinaga, M., et al. (2004). T393C polymorphism of GNAS1 associated with the autonomic nervous system in young, healthy Japanese subjects. Clin. Exp. Pharmacol. Physiol. 31:597-601.
67. Williams, S.M., Ritchie, M.D., Phillips, J.A. 3rd, Dawson, E., Prince, M., Dzhura, E., et al. (2004). Multilocus analysis of hypertension: a hierarchical approach. Hum. Hered. 57:28-38.
68. Speirs, H.J., Katyk, K., Kumar, N.N., Benjafield, A.V., Wang, W.Y., and Morris, B.J. (2004). Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J. Hypertens. 22:931-936.
69. Felder, R.A., Sanada, H., Xu, J., Yu, P.Y., Wang, Z., Watanabe, H., et al. (2002). G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc. Natl. Acad. Sci. USA 99:3872-3877.
70. Dong, Y., Zhu, H., Lu, Y., Wang, X., Harshfield, G., Snieder, H., et al. (2005). The G protein-coupled receptor kinase 4 gene affects blood pressure variation in young normotensive twins. Am. J. Hypertens. 18(Suppl. 1):A81.
71. Bengra, C., Mifflin, T.E., Khripin, Y., Manunta, P., Williams, S.M., Jose, P.A., et al. (2002). Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin. Chem. 48:2131-2140.
72. Parving, H.H., Andersen, S., Jacobsen, P., Christensen, P.K., Rossing, K., Hovind, P., et al. (2004). Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points. Semin. Nephrol. 24:147-157.
73. Anderson, E.A., Balon, T.W., Hoffman, R.P., Sinkey, C.A., and Mark, A.L. (1992). Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 19:621-627.
74. Mark, A.L., Lawton, W.J., Abboud, F.M., Fitz, A.E., Connor, W.E., and Heistad, D.D. (1975). Effects of high and low sodium intake on arterial pressure and forearm vasular resistance in borderline hypertension. A preliminary report. Circ. Res. 36:194-198.
75. Nilsson, H., Ely, D., Friberg, P., Karlstrom, G., and Folkow, B. (1985). Effects of high and low sodium diets on the resistance vessels and their adrenergic vasoconstrictor fibre control in normotensive (WKY) and hypertensive (SHR) rats. Acta Physiol. Scand. 125:323-334.
76. Harshfield, G.A., Wilson, M.E., McLeod, K., Hanevold, C., Kapuku, G.K., Mackey, L., et al. (2003). Adiposity is related to gender differences in impaired stress-induced pressure natriuresis. Hypertension 42:1082-1086.
77. Schneider, M.P., Klingbeil, A.U., Schlaich, M.P., Langenfeld, M.R., Veelken, R., and Schmieder, R.E. (2001). Impaired sodium excretion during mental stress in mild essential hypertension. Hypertension 37:923-927.
78. Grim, C.E., Miller, J.Z., Luft, F.C., Christian, J.C., and Weinberger, M.H. (1979). Genetic influences on renin, aldosterone, and the renal excretion of sodium and potassium following volume expansion and contraction in normal man. Hypertension 1:583-590.
79. Manatunga, A.K., Reister, T.K., Miller, J.Z., and Pratt, J.H. (1992). Genetic influences on the urinary excretion of aldosterone in children. Hypertension 19:192-197.
80. Siani, A., Russo, P., Paolo Cappuccio, F., Iacone, R., Venezia, A., Russo, O., et al. (2004). Combination of renin-angiotensin system polymorphisms is associated with altered renal sodium handling and hypertension. Hypertension 43:598-602.
81. Castellano, M., Glorioso, N., Cusi, D., Sarzani, R., Fabris, B., Opocher, G., et al. (2003). Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J. Hypertens. 21:1853-1860.
82. Harshfield, G.A., Wilson, M.E., Hanevold, C., Kapuku, G.K., Mackey, L., Gillis, D., et al. (2002). Impaired stress-induced pressure natriuresis increases cardiovascularload in African American youths. Am. J. Hypertens. 15:903-906.
83. Barbeau, P., Litaker, M.S., and Harshfield, G.A. (2003). Impaired pressure natriuresis in obese youths. Obes. Res. 11:745-751.
84. Wilson, M.E., Harshfield, G.A., Ortiz, L., Hanevold, C., Kapuka, G., Mackey, L., et al. (2004). Relationship of body composition to stress-induced pressure natriuresis in youth. Am. J. Hypertens. 17:1023-1028.
85. Lifton, R.P., Gharavi, A.G., and Geller, D.S. (2001). Molecular mechanisms of human hypertension. Cell 104:545-556.
86. Siffert, W., Rosskopf, D., Moritz, A., Wieland, T., Kaldenberg-Stasch, S., Kettler, N., et al. (1995). Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J. Clin. Invest. 96:759-766.
87. Pietruck, F., Moritz, A., Montemurro, M., Sell, A., Busch, S., Rosskopf, D., et al. (1996). Selectively enhanced cellular signaling by Gi proteins in essential hypertension. G alpha i2, G alpha i3, G beta 1, and G beta 2 are not mutated. Circ. Res. 79:974-983.
88. Good, D.W., George, T., and Watts, B.A. 3rd. (1995). Basolateral membrane Na+/H+ exchange enhances HCO3-absorption in rat medullary thick ascending limb: evidence for functional coupling between basolateral and apical membrane Na+/H+ exchangers. Proc. Natl. Acad. Sci. USA 92:12,525-12,529.
89. Schultheis, P.J., Clarke, L.L., Meneton, P., Miller, M.L., Soleimani, M., Gawenis, L.R., et al. (1998). Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat. Genet. 19:282-285.
90. Zhu, H.D., Sagnella, G.A., Dong, Y.B., Miller, M.A., Onipinla, A., Markandu, N.D., et al. (2004). Molecular variants of the sodium-hydrogen exchanger type 3 gene and essential hypertension. J. Hypertens. 22:1269-1275.
91. Sartori, M., Semplicini, A., Siffert, W., Mormino, P., Mazzer, A., Pegoraro, F., et al. (2003). G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension 42:909-914.
92. Schunkert, H., Hense, H.W., Doring, A., Riegger, G.A., and Siffert, W. (1998). Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 32:510-513.
93. Turner, S.T., Schwartz, G.L., Chapman, A.B., and Boerwinkle, E. (2001). C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension 37:739-743.
94. Siffert, W. (2003). G-protein beta3 subunit 825T allele and hypertension. Curr. Hypertens. Rep. 5:47-53.
95. Bianchi, G. and Tripodi, G. (2003). Genetics of hypertension: the adducin paradigm. Ann. NY Acad. Sci. 986:660-668.
96. Manunta, P., Cusi, D., Barlassina, C., Righetti, M., Lanzani, C., D'Amico, M., et al. (1998). Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int. 53:1471-1478.
97. Cusi, D., Barlassina, C., and Taglietti, M.V. (2003). Genetics of human arterial hypertension. J. Nephrol. 16:609-615.
98. Manunta, P., Burnier, M., D'Amico, M., Buzzi, L., Maillard, M., Barlassina, C., et al. (1999). Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 33:694-697.
99. Garty, H. and Palmer, L.G. (1997). Epithelial sodium channels: function, structure, and regulation. Physiol. Rev. 77:359-396.
100. Canessa, C.M., Schild, L., Buell, G., Thorens, B., Gautschi, I., Horisberger, J.D., et al. (1994). Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367:463-467.
101. Snyder, P.M., Price, M.P., McDonald, F.J., Adams, C.M., Volk, K.A., Zeiher, B.G., et al. (1995). Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel. Cell 83:969-978.
102. Firsov, D., Schild, L., Gautschi, I., Merillat, A.M., Schneeberger, E., and Rossier, B.C. (1996). Cell surface expression of the epithelial Na channel and a mutant causing Liddle syndrome: a quantitative approach. Proc. Natl. Acad. Sci. USA 93:15,370-15,375.
103. Wallin, J.D. (1986). Hypertension in black patients. Epidemiologic and pathophysiologic considerations. J. Clin. Hypertens. 2:7-12.
104. Cappuccio, F.P. (1997). Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J. Hum. Hypertens. 11:571-576.
105. Sagnella, G.A. (2001). Why is plasma renin activity lower in populations of African origin? J. Hum. Hypertens. 15:17-25.
106. He, F.J. and MacGregor, G.A. (2003). Salt, blood pressure and the renin-angiotensin system. J. Renin Angiotensin Aldosterone Syst. 4:11-16.
107. Baker, E.H., Dong, Y.B., Sagnella, G.A., Rothwell, M., Onipinla, A.K., Markandu, N.D., et al. (1998). Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet 351:1388-1392.
108. Dong, Y.B., Zhu, H.D., Baker, E.H., Sagnella, G.A., MacGregor, G.A., Carter, N.D., et al. (2001). T594M and G442V polymorphisms of the sodium channel beta subunit and hypertension in a black population. J. Hum. Hypertens. 15:425-430.
109. Baker, E.H., Ireson, N.J., Dong Y.B., Blackwood A., Sagnella G.A., Carter N.D., and MacGregor, G.A. (1998). Increased sodium channel activity in black people with the T594M epithelial sodium channel mutation. Hypertension 32:793 Abstract.
110. Ambrosius, W.T., Bloem, L.J., Zhou, L., Rebhun, J.F., Snyder, P.M., Wagner, M.A., et al. (1999). Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension. Hypertension 34:631-637.
111. Tiago, A.D., Nkeh, B., Candy, G.P., Badenhorst, D., Defterios, D., Brooksbank, R., et al. (2001). Association study of eight candidate genes with renin status in mild-to-moderate hypertension in patients of African ancestry. Cardiovasc. J. S. Afr. 12:75-80.
112. Persu, A., Barbry, P., Bassilana, F., Houot, A.M., Mengual, R., Lazdunski, M., et al. (1998). Genetic analysis of the beta subunit of the epithelial Na+ channel in essential hypertension. Hypertension 32:129-137.
113. Samaha, F.F., Rubenstein, R.C., Yan, W., Ramkumar, M., Levy, D.I., Ahn, Y.J., et al. (2004). Functional polymorphism in the carboxyl terminus of the alpha-subunit of the human epithelial sodium channel. J. Biol. Chem. 279:23,900-23,907.
114. Iwai, N., Baba, S., Mannami, T., Ogihara, T., and Ogata, J. (2002). Association of a sodium channel alpha subunit promoter variant with blood pressure. J. Am. Soc. Nephrol. 13:80-85.
115. Snyder, P.M., Olson, D.R., and Thomas, B.C. (2002). Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated inhibition of the epithelial Na+ channel. J. Biol. Chem. 277:5-8.
116. Kamynina, E. and Staub, O. (2002). Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na(+) transport. Am. J. Physiol. Renal Physiol. 283:F377-F387.
117. Gormley, K., Dong, Y., and Sagnella, G.A. (2003). Regulation of the epithelial sodium channel by accessory proteins. Biochem. J. 371:1-14.
118. Asher, C., Sinha, I., and Garty, H. (2003). Characterization of the interactions between Nedd4-2, ENaC, and sgk-1 using surface plasmonresonance. Biochim. Biophys. Acta 1612:59-64.
119. Staub, O., Dho, S., Henry, P., Correa, J., Ishikawa, T., McGlade, J., et al. (1996). WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome. EMBO J. 15:2371-2380.
120. Dinudom, A., Fotia, A.B., Lefkowitz, R.J., Young, J.A., Kumar, S., and Cook, D.I. (2004). The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na+ channels. Proc. Natl. Acad. Sci. USA 101:11,886-11,890.
121. Chen, H., Ross, C.A., Wang, N., Huo, Y., MacKinnon, D.F., Potash, J.B., et al. (2001). NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene. Eur. J. Hum. Genet. 9:922-930.
122. Alvarez de la Rosa, D., Zhang, P., Naray-Fejes-Toth, A., Fejes-Toth, G., and Canessa, C.M. (1999). The serum and glucocorticoid kinase sgk increases the abundance of epithelial sodium channels in the plasma membrane of Xenopus oocytes. J. Biol. Chem. 274:37,834-37,839.
123. Diakov, A. and Korbmacher, C. (2004). A novel pathway of epithelial sodium channel activation involves a serum-and glucocorticoid-inducible kinase consensus motif in the C terminus of the channel's alpha-subunit. J. Biol. Chem. 279:38,134-38,142.
124. Busjahn, A., Aydin, A., Uhlmann, R., Krasko, C., Bahring, S., Szelestei, T., et al. (2002). Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure. Hypertension 40:256-260.
125. Schiffrin, E.L. and Thibault, G. (1991). Plasmaendothelin in human essential hypertension. Am. J. Hypertens. 4:303-308.
126. Sander, M., Chavoshan, B., and Victor, R.G. (1999). A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33:937-942.
127. Spieker, L.E., Hurlimann, D., Ruschitzka, F., Corti, R., Enseleit, F., Shaw, S., et al. (2002). Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation 105:2817-2820.
128. Panza, J.A., Casino, P.R., Kilcoyne, C.M., and Quyyumi, A.A. (1993). Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87:1468-1474.
129. Taddei, S. and Salvetti, A. (1996). Pathogenetic factors in hypertension. Endothelial factors. Clin. Exp. Hypertens. 18:323-335.
130. Vanhoutte, P.M. (2004). Endothelium-dependent hyperpolarizations: the history. Pharmacol. Res. 49:503-508.
131. Wang, X.L., Mahaney, M.C., Sim, A.S., Wang, J., Blangero, J., Almasy, L., et al. (1997). Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 17:3147-3153.
132. Treiber, F.A., Barbeau, P., Harshfield, G., Kang, H.S., Pollock, D.M., Pollock, J.S., et al. (2003). Endothelin-1 gene Lysl98Asn polymorphism and blood pressure reactivity. Hypertension 42:494-499.
133. Malhotra, S., Poole, J., Davis, H., Dong, Y., Pollock, J., Snieder, H., et al. (2004). Effects of NOS3 Glu298Asp polymorphism on hemodynamic reactivity to stress: influences of ethnicity and obesity. Hypertension 44:866-871.
134. Dong, Y., Wang, X., Zhu, H., Treiber, F.A., and Snieder, H. (2004). Endothelin-1 gene and progression of blood pressure and left ventricular mass: longitudinal findings in youth. Hypertension 44:884-890.
135. Zhu, H., Wang, X., Dong, Y., Treiber, F.A., and Snieder, H. (2005). Influence of the endothelial nitric oxide synthase gene on longitudinal development of blood pressure and left ventricular mass in African-American and European-American youth. Circulation 111:e222 p190.
136. Schwartz, P.J., Vanoli, E., Stramba-Badiale, M., De Ferrari, G.M., Billman, G.E., and Foreman, R.D. (1988). Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78:969-979.
137. La Rovere, M.T., Bersano, C., Gnemmi, M., Specchia, G., and Schwartz, P.J. (2002). Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 106:945-949.
138. Kleiger, R.E., Miller, J.P., Bigger, J.T. Jr., and Moss, A.J. (1987). Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am. J. Cardiol. 59:256-262.
139. Bigger, J.T., Fleiss, J.L., Rolnitzky, L.M., and Steinman, R.C. (1993). The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation 88:927-934.
140. Reinhardt, L., Makijarvi, M., Fetsch, T., Martinez-Rubio, A., Bocker, D., Block, M., et al. (1996). Reduced beat-to-beat changes of heart rate: an important risk factor after acute myocardial infarction. Cardiology 87:104-111.
141. Tsuji, H., Larson, M.G., Venditti, F.J. Jr., Manders, E.S., Evans, J.C., Feldman, C.L., et al. (1996). Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 94:2850-2855.
142. Dekker, J.M., Schouten, E.G., Klootwijk, P., Pool, J., Swenne, C.A., and Kromhout, D. (1997). Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am. J. Epidemiol. 145:899-908.
143. Julius, S. (1991). Autonomic nervous system dysregulation in human hypertension. Am. J. Cardiol. 67:3B-7B.
144. Liao, D., Cai, J., Barnes, R.W., Tyroler, H.A., Rautaharju, P., Holme, I., et al. (1996). Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am. J. Hypertens. 9:1147-1156.
145. Singh, J.P., Larson, M.G., Tsuji, H., Evans, J.C., O'Donnell, C.J., and Levy, D. (1998). Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 32:293-297.
146. Maver, J., Strucl, M., and Accetto, R. (2004). Autonomic nervous system and microvascular alterations in normotensives with a family history of hypertension. Blood Press. 13:95-100.
147. Vrijkotte, T.G., van Doornen, L.J., and de Geus, E.J. (2000). Effects of work stress on ambulatory blood pressure, heart rate, and heart rate variability. Hypertension 35:880-886.
148. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996). Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-1065.
149. Boomsma, D.I., van Baal, G.C., and Orlebeke, J.F. (1990). Genetic influences on respiratory sinus arrhythmia across different task conditions. Acta Genet. Med. Gemellol. (Roma) 39:181-191.
150. Busjahn, A., Voss, A., Knoblauch, H., Knoblauch, M., Jeschke, E., Wessel, N., et al. (1998). Angiotensin-converting enzyme and angiotensinogen gene polymorphisms and heart rate variability in twins. Am. J. Cardiol. 81:755-760.
151. De Geus, E.J., Boomsma, D.I., and Snieder, H. (2003). Genetic correlation of exercise with heart rate and respiratory sinus arrhythmia. Med. Sci. Sports Exerc. 35:1287-1295.
152. Snieder, H., Boomsma, D.I., Van Doornen, L.J., and De Geus, E.J. (1997). Heritability of respiratory sinus arrhythmia: dependency on task and respiration rate. Psychophysiol. 34:317-328.
153. Kupper, N.H., Willemsen, G., van den Berg, M., de Boer, D., Posthuma, D., Boomsma, D.I., et al. (2004). Heritability of ambulatory heart rate variability. Circulation 110:2792-2796.
154. Singh, J.P., Larson, M.G., O'Donnell, C.J., Tsuji, H., Evans, J.C., and Levy, D. (1999). Heritability of heart rate variability: the Framingham Heart Study. Circulation 99:2251-2254.
155. Sinnreich, R., Friedlander, Y., Luria, M.H., Sapoznikov, D., and Kark, J.D. (1999). Inheritance of heart rate variability: the kibbutzim family study. Hum. Genet. 105:654-661.
156. Dubreuil, E., Ditto, B., Dionne, G., Pihl, R.O., Tremblay, R.E., Boivin, M., et al. (2003). Familiality of heart rate and cardiac-related autonomic activity in five-month-old twins: the Quebec newborn twins study. Psychophysiol. 40:849-862.
157. Wang, X., Thayer, J.F., Treiber, F.A., and Snieder, H. (2005). Ethnic differences and heritability of heart rate variability in African and European American youth. Circulation 111:e222 p169.
158. Neumann, S.A., Lawrence, B.A., Jennings, J.R., Ferrell, R.E., and Manuck, S.B. (in press). Heart rate variability is associated with a polymorphism of the choline transporter gene (CHT1). Psychosom. Med.
159. Suzuki, N., Matsunaga, T., Nagasumi, K., Yamamura, T., Shihara, N., Moritani, T., et al. (2003). Alpha(2B)-adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese. J. Clin. Endocrinol. Metab. 88:1184-1187.
160. Thayer, J.F., Merritt, M.M., Sollers, J.J. 3rd, Zonderman, A.B., Evans, M.K., Yie, S., et al. (2003). Effect of angiotensin-converting enzyme insertion/deletion polymorphism DD genotype on high-frequency heart rate variability in African Americans. Am. J. Cardiol. 92:1487-1490.
161. Stolarz, K., Staessen, J.A., Kawecka-Jaszcz, K., Brand, E., Bianchi, G., Kuznetsova, T., et al. (2004). Genetic variation in CYP11B2 and AT1R influences heart rate variability conditional on sodium excretion. Hypertension 44:156-162.
162. Singh, J.P., Larson, M.G., O'Donnell, C.J., Tsuji, H., Corey, D., and Levy, D. (2002). Genome scan linkage results for heart rate variability (the Framingham Heart Study). Am. J. Cardiol. 90:1290-1293.
163. Wickman, K., Nemec, J., Gendler, S.J., and Clapham, D.E. (1998). Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20:103-114.
164. Rotondo, A., Schuebel, K., Bergen, A., Aragon, R., Virkkunen, M., Linnoila, M., et al. (1999). Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol. Psychiatry 4:360-368.
165. Zill, P., Baghai, T.C., Zwanzger, P., Schule, C., Eser, D., Rupprecht, R., et al. (2004). SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol. Psychiatry 9:1030-1036.
166. Tsai, S.J., Hong, C.J., Hsu, C.C., Cheng, C.Y., Liao, W.Y., Song, H.L., et al. (1999). Serotonin-2A receptor polymorphism (102T/C) in mood disorders. Psychiatry Res. 87:233-237.
167. Oruc, L., Verheyen, G.R., Furac, I., Jakovljevic, M., Ivezic, S., Raeymaekers, P., et al. (1997). Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder. Am. J. Med. Genet. 74:504-506.
168. Jonsson, E.G., Norton, N., Gustavsson, J.P., Oreland, L., Owen, M.J., and Sedvall, G.C. (2000). A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J. Psychiatr. Res. 34:239-244.
169. Manuck, S.B., Flory, J.D., Ferrell, R.E., Mann, J.J., and Muldoon, M.F. (2000). A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res. 95:9-23.
170. Lesch, K.P., Balling, U., Gross, J., Strauss, K., Wolozin, B.L., Murphy, D.L., et al. (1994). Organization of the human serotonin transporter gene. J. Neural Transm. Gen. Sect. 95:157-162.
171. Heils, A., Teufel, A., Petri, S., Seemann, M., Bengel, D., Balling, U., et al. (1995). Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J. Neural Transm. Gen. Sect. 102:247-254.
172. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D., et al. (1996). Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66:2621-2624.
173. Williams, R.B., Marchuk, D.A., Gadde, K.M., Barefoot, J.C., Grichnik, K., Helms, M.J., et al. (2001). Central nervous system serotonin function and cardiovascular responses to stress. Psychosom. Med. 63:300-305.
174. Greenberg, B.D., Tolliver, T.J., Huang, S.J., Li, Q., Bengel, D., and Murphy, D.L. (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 88:83-87.
175. Ljung, T., Ahlberg, A.C., Holm, G., Friberg, P., Andersson, B., Eriksson, E., et al. (2001). Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study. J. Intern. Med. 250:219-224.
176. Golding, M., Kotlyar, M., Garbutt, J.C., Guzzo, J., Sontz, E., Hinderliter, A., et al. (2002). Paroxetine modulates psychological and sympathetic responses during public speaking. J. Clin. Psychopharmacol. 22:98-99.
177. Kemp, A.H. and Nathan, P.J. (2004). Acute augmentation of serotonin suppresses cardiovascular responses to emotional valence. Int. J. Neuropsychopharmacol. 7:65-70.
178. McCaffery, J.M., Bleil, M., Pogue-Geile, M.F., Ferrell, R.E., and Manuck, S.B. (2003). Allelic variation in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cardiovascular reactivity in young adult male and female twins of European-American descent. Psychosom. Med. 65:721-728.
179. Ramasubbu, R. (2003). Serotonin transporter gene functional polymorphism: a plausible candidate gene for increased vascular risk in depression. Med. Hypotheses 61:36-44.
180. Naesh, O., Haedersdal, C., Hindberg, I., and Trap-Jensen, J. (1993). Platelet activation in mental stress. Clin. Physiol. 13:299-307.
181. Steptoe, A., Magid, K., Edwards, S., Brydon, L., Hong, Y., and Erusalimsky, J. (2003). The influence of psychological stress and socioeconomic status on platelet activation in men. Atherosclerosis 168:57-63.
182. Strike, P.C., Magid, K., Brydon, L., Edwards, S., McEwan, J.R., and Steptoe, A. (2004). Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychosom. Med. 66:492-500.
183. Ramamoorthy, S., Bauman, A.L., Moore, K.R., Han, H., Yang-Feng, T., Chang, A.S., et al. (1993). Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90:2542-2546.
184. Whyte, E.M., Pollock, B.G., Wagner, W.R., Mulsant, B.H., Ferrell, R.E., Mazumdar, S., et al. (2001). Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am. J. Psychiatry 158:2074-2076.
185. McEwen, B.S. (2003). Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. Metabolism 52:10-16.
186. Bartels, M., Van den Berg, M., Sluyter, F., Boomsma, D.I., and de Geus, E.J. (2003). Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology 28:121-137.
187. Bartels, M., de Geus, E.J., Kirschbaum, C., Sluyter, F., and Boomsma, D.I. (2003). Heritability of daytime cortisol levels in children. Behav. Genet. 33:421-433.
188. Federenko, I.S., Nagamine, M., Hellhammer, D.H., Wadhwa, P.D., and Wust, S. (2004). The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. J. Clin. Endocrinol. Metab. 89:6244-6250.
189. New, M.I. (2002). Hypertension in congenital adrenal hyperplasia and apparent mineralocorticoid excess. Ann. NY Acad. Sci. 970:145-154.
190. Lifton, R.P., Dluhy, R.G., Powers, M., Rich, G.M., Cook, S., Ulick, S., et al. (1992). A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262-265.
191. Ferrari, P., Lovati, E., and Frey, F.J. (2000). The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J. Hypertens. 18:241-248.
192. White, P.C. (2001). 11beta-hydroxy steroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Am. J. Med. Sci. 322:308-315.
193. Beretta-Piccoli, C., Davies, D.L., Boddy, K., Brown, J.J., Cumming, A.M., East, B.W., et al. (1982). Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin. Sci. (Lond.) 63:257-270.
194. Walker, B.R., Stewart, P.M., Shackleton, C.H., Padfield, P.L., and Edwards, C.R. (1993). Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension. Clin. Endocrinol. (Oxf.) 39:221-227.
195. Soro, A., Ingram, M.C., Tonolo, G., Glorioso, N., and Fraser, R. (1995). Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension. Hypertension 25:67-70.
196. Watson, B. Jr., Bergman, S.M., Myracle, A., Callen, D.F., Acton, R.T., and Warnock, D.G. (1996). Genetic association of 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks. Hypertension 28:478-482.
197. White, P.C., Agarwal, A.K., Li, A., Nikkila, H., Pratt, J.H., Caulfield, M., et al. (2001). Possible association but no linkage of the HSD11B2 gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase to hypertension in Black people. Clin. Endocrinol. (Oxf.) 55:249-252.
198. Brand, E., Kato, N., Chatelain, N., Krozowski, Z.S., Jeunemaitre, X., Corvol, P., et al. (1998). Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension. J. Hypertens. 16:1627-1633.
199. Melander, O., Orho-Melander, M., Bengtsson, K., Lindblad, U., Rastam, L., Groop, L., et al. (2000). Association between a variant in the 11 beta-hydroxysteroid dehydrogenase type 2 gene and primary hypertension. J. Hum. Hypertens. 14:819-823.
200. Smolenicka, Z., Bach, E., Schaer, A., Liechti-Gallati, S., Frey, B.M., Frey, F.J., et al. (1998). A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. J. Clin. Endocrinol. Metab. 83:1814-1817.
201. Lavery, G.G., McTernan, C.L., Bain, S.C., Chowdhury, T.A., Hewison, M., and Stewart, P.M. (2002). Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy. Eur. J. Endocrinol. 146:553-558.
202. Draper, N., Echwald, S.M., Lavery, G.G., Walker, E.A., Fraser, R., Davies, E., et al. (2002). Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J. Clin. Endocrinol. Metab. 87:4984-4990.
203. Agarwal, A.K., Giacchetti, G., Lavery, G., Nikkila, H., Palermo, M., Ricketts, M., et al. (2000). CA-Repeat polymorphism in intron 1 of HSD11B2: effects on gene expression and salt sensitivity. Hypertension 36:187-194.
204. Poch, E., Gonzalez, D., Giner, V., Bragulat, E., Coca, A., and de La Sierra, A. (2001). Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 38:1204-1209.
205. Keavney, B., Mayosi, B., Gaukrodger, N., Imrie, H., Baker, M., Fraser, R., et al. (2005). Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. J. Clin. Endocrinol. Metab. 90:1072-1077.
206. Connell, J.M., Fraser, R., MacKenzie, S., and Davies, E. (2003). Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? Hypertension 41:993-999.
207. Lin, R.C., Wang, W.Y., and Morris, B.J. (1999). Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension. Hypertension 34:1186-1192.
208. Rosmond, R. (2002). The glucocorticoid receptor gene and its association to metabolic syndrome. Obes. Res. 10:1078-1086.
209. Wust, S., Van Rossum, E.F., Federenko, I.S., Koper, J.W., Kumsta, R., and Hellhammer, D.H. (2004). Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J. Clin. Endocrinol. Metab. 89:565-573.
210. Ferrari, P. and Krozowski, Z. (2000). Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation. Kidney Int. 57:1374-1381.